Zura Bio
ZURA
69 hedge funds and large institutions have $179M invested in Zura Bio in 2025 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 15 increasing their positions, 25 reducing their positions, and 14 closing their positions.
383% more capital invested
Capital invested by funds: $37.1M → $179M (+$142M)
29% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 14
12.02% more ownership
Funds ownership: 51.65% → 63.67% (+12%)
6% more funds holding
Funds holding: 65 → 69 (+4)
39% less call options, than puts
Call options by funds: $373K | Put options by funds: $610K
40% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 25
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
+$5.48M |
| 2 |
IC
Ikarian Capital
Dallas,
Texas
|
+$3.83M |
| 3 |
AAA
Affinity Asset Advisors
New York
|
+$1.89M |
| 4 |
BFM
Boothbay Fund Management
New York
|
+$1.48M |
| 5 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
+$1.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$2.92M |
| 2 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$2.64M |
| 3 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
-$621K |
| 4 |
Goldman Sachs
New York
|
-$397K |
| 5 |
BlackRock
New York
|
-$382K |
ZURA Hedge Fund Activity: Q3 2025 in Review
69 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Zura Bio (ZURA) for Q3 2025, worth a combined $179M — up 383% from $37.1M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new ZURA positions and 14 closed out — a net gain of 4 holders — while 15 added to existing stakes and 25 trimmed.
The largest buyer was Adage Capital Partners, opening a new position worth an estimated $5.48M. The largest seller was Point72 Asset Management, cutting an estimated $2.92M.
- 69 institutional investors held Zura Bio (ZURA) as of Q3 2025, up from 65 in Q2 2025.
- Funds reported $179M of Zura Bio stock for Q3 2025, up 383% quarter-over-quarter.
- 18 funds opened new Zura Bio positions in Q3 2025 and 14 closed out, a net change of +4 holders.
- The largest Zura Bio buyer in Q3 2025 was Adage Capital Partners, an estimated $5.48M added.
- The largest Zura Bio seller in Q3 2025 was Point72 Asset Management, an estimated $2.92M sold.
Based on aggregated 13F filings for Q3 2025.